CLINICAL_TRIALS
trial_result
· 2011-12-22
Clinical Trial Update: A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma [Phase 2]
Summary
Phase 2 trial of vemurafenib in patients with previously treated metastatic melanoma. Results from the study have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2011-12-22